Aeternum Health (AETN) Common Equity (2011 - 2026)

Aeternum Health has disclosed Common Equity across 16 years of filings, most recently posting -$2.1 million for Q1 2026.

• In Q1 2026, Common Equity fell 24.53% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$2.1 million (down 24.53% YoY), while the FY2025 annual figure was -$2.0 million, down 19.26% from the prior year.
• Common Equity declined to -$2.1 million in Q1 2026, from -$2.0 million in the prior quarter.
• Over the last five years, Common Equity for AETN reached as high as -$846521.0 in Q1 2023 and fell as low as -$2.1 million in Q1 2026.
• The 5-year median for Common Equity is -$1.5 million (2024), against an average of -$1.5 million.
• Annual changes were most pronounced in 2022 — Common Equity tumbled 623.27% — and 2023, when it surged 46.96%.
• A 5-year view of Common Equity shows it stood at -$1.2 million in 2022, then rose by 2.52% to -$1.2 million in 2023, then slumped by 41.53% to -$1.7 million in 2024, then dropped by 19.26% to -$2.0 million in 2025, then declined by 3.16% to -$2.1 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$2.1 million, -$2.0 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.